Literature DB >> 27608291

Perturbation of Akt Signaling, Mitochondrial Potential, and ADP/ATP Ratio in Acidosis-Challenged Rat Cortical Astrocytes.

King-Chuen Wu1,2, Ka-Shun Cheng3,4, Yu-Wen Wang5, Yuh-Fung Chen6, Kar-Lok Wong3, Tzu-Hui Su3, Paul Chan7, Yuk-Man Leung8.   

Abstract

Cells switch to anaerobic glycolysis when there is a lack of oxygen during brain ischemia. Extracellular pH thus drops and such acidosis causes neuronal cell death. The fate of astrocytes, mechanical, and functional partners of neurons, in acidosis is less studied. In this report, we investigated the signaling in acidosis-challenged rat cortical astrocytes and whether these signals were related to mitochondrial dysfunction and cell death. Exposure to acidic pH (6.8, 6.0) caused Ca2+ release and influx, p38 MAPK activation, and Akt inhibition. Mitochondrial membrane potential was hyperpolarized after astrocytes were exposed to acidic pH as soon as 1 h and lasted for 24 h. Such mitochondrial hyperpolarization was prevented by SC79 (an Akt activator) but not by SB203580 (a p38 inhibitor) nor by cytosolic Ca2+ chelation by BAPTA, suggesting that only the perturbation in Akt signaling was causally related to mitochondrial hyperpolarization. SC79, SB203580, and BAPTA did not prevent acidic pH-induced cell death. Acidic pH suppressed ROS production, thus ruling out the role of ROS in cytotoxicity. Interestingly, pH 6.8 caused an increase in ADP/ATP ratio and apoptosis; pH 6.0 caused a further increase in ADP/ATP ratio and necrosis. Therefore, astrocyte cell death in acidosis did not result from mitochondrial potential collapse; in case of acidosis at pH 6.0, necrosis might partly result from mitochondrial hyperpolarization and subsequent suppressed ATP production. J. Cell. Biochem. 118: 1108-1117, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ACIDOSIS; AKT; ASTROCYTES; MITOCHONDRIA HYPERPOLARIZATION

Mesh:

Substances:

Year:  2017        PMID: 27608291     DOI: 10.1002/jcb.25725

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Inhibition of RhoA-Subfamily GTPases Suppresses Schwann Cell Proliferation Through Regulating AKT Pathway Rather Than ROCK Pathway.

Authors:  Dandan Tan; Jinkun Wen; Lixia Li; Xianghai Wang; Changhui Qian; Mengjie Pan; Muhua Lai; Junyao Deng; Xiaofang Hu; Haowen Zhang; Jiasong Guo
Journal:  Front Cell Neurosci       Date:  2018-11-20       Impact factor: 5.505

2.  Activation of TGR5 Ameliorates Streptozotocin-Induced Cognitive Impairment by Modulating Apoptosis, Neurogenesis, and Neuronal Firing.

Authors:  Ronghao Mu; Xian Wu; Danhua Yuan; Jiajia Zhao; Susu Tang; Hao Hong; Yan Long
Journal:  Oxid Med Cell Longev       Date:  2022-04-15       Impact factor: 7.310

3.  The TSPO Ligands MGV-1 and 2-Cl-MGV-1 Differentially Inhibit the Cigarette Smoke-Induced Cytotoxicity to H1299 Lung Cancer Cells.

Authors:  Nidal Zeineh; Rafael M Nagler; Martin Gabay; Fadi Obeid; Meygal Kahana; Abraham Weizman; Moshe Gavish
Journal:  Biology (Basel)       Date:  2021-05-02

4.  Dexmedetomidine alleviated neuropathic pain in dorsal root ganglion neurons by inhibition of anaerobic glycolysis activity and enhancement of ROS tolerance.

Authors:  Peibin Liu; Tufeng Chen; Fang Tan; Jingling Tian; Lei Zheng; Yingqing Deng; Jiaxin Chen; Xinjin Chi
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

5.  Efficaciousness of Low Affinity Compared to High Affinity TSPO Ligands in the Inhibition of Hypoxic Mitochondrial Cellular Damage Induced by Cobalt Chloride in Human Lung H1299 Cells.

Authors:  Nidal Zeineh; Nunzio Denora; Valentino Laquintana; Massimo Franco; Abraham Weizman; Moshe Gavish
Journal:  Biomedicines       Date:  2020-05-02

6.  Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Dan He; Qiang Li; Guangli Du; Jijia Sun; Guofeng Meng; Shaoli Chen
Journal:  Biomed Res Int       Date:  2021-11-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.